Bacterial Biosensor IDs Endocrine-Disrupting Chemicals

Using freeze-dried E. coli and disposable electrodes, scientists engineer a sensor that can quickly detect EDCs.

Written byDiana Kwon
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

AMERICAN CHEMICAL SOCIETY Exposure to endocrine-disrupting chemicals (EDCs), compounds that interfere with native hormonal receptors, has been associated with everything from obesity to cancer. EDCs are present in a variety of consumer products—bisphenol A (BPA), for example, can be found in some plastic containers. Although these compounds are not trivial to find, last month (January 11) in ACS Central Science, a team at the University of California, Berkeley, reported on a new method for detection, which it developed using Escherichia coli bacteria.

“There are many [endocrine-disrupting] compounds found in the environment now due to pollution, fracking and other kinds of industrial processes,” said study coauthor Ariel Furst, a postdoctoral fellow at UC Berkeley. These compounds “can have [a] detrimental effect on health, leading to diseases and [other] problems,” she added.

E. coli cells naturally express estrogen receptors on their surfaces. Taking advantage of this, Furst and colleagues created an “electrochemical sandwich assay” with two components: freeze-dried bacteria that had been engineered to display estrogen receptors on their surfaces and disposable electrodes, which the researchers modified with proteins that bind to the estrogen receptor only when EDCs are present. “The way the electrochemical technique works is that it basically just measures how much of your surface is blocked,” ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Diana is a freelance science journalist who covers the life sciences, health, and academic life. She’s a regular contributor to The Scientist and her work has appeared in several other publications, including Scientific American, Knowable, and Quanta. Diana was a former intern at The Scientist and she holds a master’s degree in neuroscience from McGill University. She’s currently based in Berlin, Germany.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies